|
Ipilimumab plus nivolumab Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 2: 1
Top Sponsors
- UNC Lineberger Comprehensive Cancer Center1
Indications
- Melanoma Stage M11
- Melanoma Stage Stage IIIB1
- Melanoma Stage IV1
- Melanoma (Skin Cancer)1
- Cancer1
Chapel Hill, North Carolina1 trial
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
Lineberger Comprehensive Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.